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PCardiovascular Effects of Sleep Apnea
bstructive Sleep Apnea Syndrome
ore Insights on Structural and Functional Cardiac Alterations,
nd the Effects of Treatment With Continuous Positive Airway Pressure
harati Shivalkar, MD, PHD, Caroline Van De Heyning, BSC, Mieke Kerremans, BSC,
iana Rinkevich, MD, Johan Verbraecken, MD, PHD, Wilfried De Backer, MD, PHD,
hristiaan Vrints, MD, PHD
ntwerp, Belgium
OBJECTIVES We studied structural and functional cardiac alterations in obstructive sleep apnea (OSA),
their relationship to the severity of OSA, and the effects of treatment with continuous positive
airway pressure (CPAP).
BACKGROUND Obstructive sleep apnea may influence the cardiac function by several mechanisms in the
awake patient.
METHODS Left and right ventricular morphology and function were studied using echocardiography before
and after treatment with CPAP in symptomatic patients (Epworth sleepiness score, 10  4.8)
with severe OSA (apnea-hypopnea index [AHI], 42  24). The patients (n  43, 32 men)
had no known cardiac disease and were obese (body mass index, 31.6 5.4 kg/m2). The same
echocardiographic parameters were studied in age-matched overweight patients (n  40;
body mass index, 26.4  2.3 kg/m2).
RESULTS The patients were hypertensive (systolic blood pressure, 153  25 mm Hg), with a higher
resting heart rate (77  10 beats/min, p  0.008) compared with age-matched control
patients (n  40). There was right ventricular dilatation, hypertrophic interventricular
septum, reduced left ventricular stroke volume, tissue Doppler-determined systolic and
diastolic velocities of the left and right ventricle, and normal pulmonary artery pressure. The
structural and functional parameters were significantly associated with AHI (p  0.004).
Multiple stepwise regression showed the interventricular septum thickness, right ventricular
free wall, and mitral annulus tissue Doppler systolic velocities to be predictive of a higher AHI
(p 0.001). Six months after treatment with CPAP, significant improvements were observed
in the symptoms and hemodynamics, as well as left and right ventricular morphology and
function.
CONCLUSIONS The structural and functional consequences of OSA on the heart are influenced by the severity
of AHI. These effects are reversible if the apneic episodes are abolished. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.0542006;47:1433–9) © 2006 by the American College of Cardiology Foundation
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Abstructive sleep apnea (OSA) is a common sleep-related
reathing disorder associated with increased risk of cardio-
ascular disease. The OSA syndrome is characterized by
epeated partial or complete closure of the pharynx, gasping
pisodes, sleep fragmentation, and daytime sleepiness (1).
he physiologic consequences of these episodes are
epetitive bursts of sympathetic activity, hypoxia, hyper-
apnia, increased left ventricular afterload, and acute
ypertension (2).
It was commonly thought to affect obese middle-aged
en (3), but it seems that one-third of the patients are
omen (2,4). Also, obesity is not a prerequisite, especially in
lder patients (5) or in those from Southeast Asia (6).
The association of OSA and heart failure is already
nown (7–9). Recently OSA has been recognized as an
From the Departments of Cardiology and Pulmonary Medicine, University
ospital Antwerp, Antwerp, Belgium. Presented in part at the European Society of
ardiology, Vienna, August 2003, and the Euroecho Scientific Sessions, Athens,
reece, December 2004.i
Manuscript received July 14, 2005; revised manuscript received October 10, 2005,
ccepted November 8, 2005.ndependent risk factor for hypertension, and to impose several
dverse effects on the heart and cardiovascular system (10).
lso, a large proportion (40% to 80%) of stroke patients
ave OSA, suggesting that it may increase the stroke risk
eyond direct effects on blood pressure level and variability
11,12). Furthermore, episodes of nocturnal ischemia, in-
reased incidence of sudden death during sleeping hours,
arly morning acute coronary events, and increased preva-
ence of arrhythmias in association with OSA have also been
eported (13–17).
Clinical management of OSA patients is primarily done
y sleep physicians with a background in respiratory med-
cine or neurology. Atypical presentations may, however, be
ommon, and patients may remain asymptomatic from
pneas, presenting instead with hypertension, arrhythmias,
r congestive cardiac failure to a cardiologist (18). Estab-
ished definitions of OSA are based on respiratory and
europhysiologic parameters; however, recent data show
hat cardiovascular consequences may be more important.
dditional, technically simple diagnostic approaches involv-
ng study of cardiovascular structural and functional param-
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Obstructive Sleep Apnea and Cardiac Alterations April 4, 2006:1433–9ters could therefore be useful. Left ventricular hypertrophy
ith systolic and diastolic dysfunction have been reported
19,20), however, there are few and inconsistent data on
tructural and functional changes of the right heart. It seems
easible that both left and right ventricles could be affected
y the effects of hypoxia and the increased sympathetic
rive.
We hypothesized that left and right ventricular morphology
nd function are affected by the effects of obstructive apnea.
e further sought to assess the relationship of possible
tructural and functional alterations to the severity of obstruc-
ive apneas, and observed the effects of treatment with
ontinuous positive airway pressure (CPAP) after six
onths on these parameters.
ETHODS
atients. Forty-three (32 male) consecutively eligible pa-
ients between the ages of 29 and 77 years (mean, 55.2 
1.6 years) were included in the study. All patients had a
istory of snoring, a variable degree of daytime sleepiness,
ere without evidence of cardiac problems, and were gen-
rally in good health (see Table 1 for patient characteristics).
bstructive sleep apnea was confirmed by polysomnogra-
hy. A physical examination and electrocardiogram were
erformed, as well as complete two-dimensional and Dopp-
Abbreviations and Acronyms
AHI  apnea-hypopnea index
BMI  body mass index
CPAP  continuous positive airway pressure
EEG  electroencephalogram
ESS  Epworth sleepiness scale
OSA  obstructive sleep apnea
Table 1. Clinical Characteristics and Baseline Ec
Age (yrs), male/female
Body mass index (kg/m2) 3
Heart rate (beats/min)
Systolic/diastolic blood pressure (mm Hg)
Smoking
Arterial hypertension
Diabetes mellitus
Chronic obstructive pulmonary disease
Cardiac disease
Right ventricle dimension (cm)
Left ventricular ejection fraction, %
Stroke volume (ml)
Performance index (left ventricle) 0
Performance index (right ventricle) 0
Isovolumic relaxation time (ms)
Interventricular septum thickness (cm) 1
Pulmonary artery pressure (mm Hg)
Mitral annular Sm (cm/s)
Tricuspid annular Sm (cm/s) 1
Right ventricle Sm (cm/s) 1Sm  systolic tissue Doppler velocity.er echocardiography. All patients completed a question-
aire to assess the Epworth sleepiness scale (ESS) (18),
hich is a rapid, validated method for screening of daytime
leepiness and is useful both in clinical practice and in
esearch settings. Informed consent was obtained from all
atients, and the study was approved by the institutional
thical committee. Patients were reassessed after 6 months
f CPAP treatment given via nasal mask.
olysomnography. A full polysomnography was per-
ormed in all patients. Electrodes for electroencephalogram
EEG) registration were applied according to standard
riteria, using frontal, central, and occipital head electrodes
ith reference electrodes at the mastoids. Central EEG
C4-A1/C3-A2), frontal EEG (C4-F4), and occipital EEG
A1-O2) recordings were obtained. Electro-oculogram
lectrodes were placed at the outer canthi of the orbits, and
n electromyelogram was measured using thermocouples at
he nose and mouth. Ribcage and abdominal movements
ere analyzed by respiratory inductance plethysmography.
xygen saturation was measured by pulse oximeter (Ohm-
da Biox, Louisville, Colorado). Sleep stages were recorded
ccording to the classic Rechtschaffen and Kales criteria
21). Data were analyzed with a semi-automatic system
Oxford Medilog SAC, Oxford Instruments, Oxford,
nited Kingdom), allowing visual scoring in addition.
pnea was defined as interruption of the oronasal airflow.
ypopnea was defined as a reduction in airflow with a 50%
eduction in thoracic and abdominal efforts for at least 10 s,
nd a 3% drop in oxygen saturation from the preceding
table saturation, and/or arousal. Apnea-hypopnea index
AHI) was the sum of the number of apneas and hypopneas
er hour of sleep. Pulmonary function tests were obtained
ith the patients in a standing position and breathing room
ir. Forced spirometry was obtained using a pneumotacho-
rdiographic Data
ts (n  43) Control Patients (n  40)
11, 32/11 50  16, 28/12
5.4 26.4  2.3 (p  0.001)
10 68  6 (p  0.008)
25/88  17 132  10/78  8 (p  0.01)
43 (28%) —
43 (51%) —
43 (0.05%) —
— —
— —
0.43 2.6  0.51 (p  0.001)
9 68  5 (p  0.012)
16 72  12 (p  0.008)
0.06 0.24  0.03 (p  0.005)
0.05 0.25  0.03 (p  0.008)
10 74  8 (p  0.001)
0.11 0.94  0.18 (p  0.001)
10 22  8 (p  0.004)
1.7 9.9  1.6 (p  0.001)
2.1 15.2  2.2 (p  0.004)
2.3 13.5  1.8 (p  0.001)hoca
Patien
55 
1.6 
77 
153 
12/
22/
2/
3.3 
62 
66 
.31 
.29 
88 
.32 
32 
8.3 
3.4 
1.4 
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ung volumes and resistance were determined using body
lethysmography (Bodytest, Jaeger). Arterial blood gases
ere processed immediately in an analyzer.
chocardiography. All imaging was performed using Sonos
500 (Philips, Eindhoven, the Netherlands). A standard
wo-dimensional and Doppler echocardiographic study was
erformed. Left ventricular ejection fraction was deter-
ined in M-mode (Teicholz) at the parasternal short axis.
eft ventricular hypertrophy was defined as interventricular
eptum thickness of 1.3 cm. Mitral and tricuspid valve
nflow velocities were measured (early rapid filling wave, E;
ate filling wave, A), as well as deceleration time (mitral
alve), isovolumic relaxation time for the left ventricle, and
ulmonary vein signals. Pulsed wave tissue Doppler systolic
nd diastolic (early; late) velocities (unit, cm/s) were ob-
ained from the mitral valve annulus, tricuspid valve annu-
us, and right ventricular free wall. Gain settings were
djusted carefully, and the direction of motion was aligned
ith the scan line direction. Signals were obtained from
hree end expiratory cycles, and averages were made for the
ystolic and diastolic velocities. Tissue Doppler velocities
ffer a robust and sensitive assessment of the regional
ystolic and diastolic function. Because tissue Doppler
elocities vary between the left and right heart, and accord-
ng to age, the systolic and diastolic velocities were compared
ith those of age-matched control patients. We also assessed
he left and right ventricular performance index, which con-
eptually combines the systolic and the diastolic function and is
etermined by the ratio of the sum of the isovolumic times
ivided by the ejection time.
ontrol patients. Forty healthy age- and gender-matched
atients were recruited after informed consent (age range,
6 to 70 years; 28 men). A complete medical history was
btained, and a physical examination and echocardiographic
tudy were performed. Patients were all lifelong nonsmokers
ithout evidence of obstructive pulmonary disease. None
ad arterial hypertension, diabetes, or hyperlipidemia; had
o family history of premature vascular disease; nor took
egular medications. There was no polysomnography per-
ormed, but the ESS was 0 in all.
tatistical analysis. All data are expressed as mean  SD.
inear regressions were performed to assess eventual rela-
ionships between the various structural, functional, and
emodynamic parameters measured. Stepwise multiple re-
ression was performed to determine whether severity of
bstructive apneas could predict changes in structural or
unctional parameters. Paired Student t test was used to
ompare differences between OSA patients before and after
reatment with CPAP. Unpaired or two-sample indepen-
ent groups t test was used to compare differences between
SA patients and control patients. A p value of 0.05 was
onsidered a significant difference. All statistical calculations
ere performed using Statview 5 (SAS Institute Inc.,
ary, North Carolina). aESULTS
he clinical characteristics and other data are presented in
able 1. The patients had significant levels of daytime
leepiness (ESS, 10.5  4.6 with a maximum possible score
f 24) and severe OSA (AHI, 42  24). The lung function
ests did not show obstructive pulmonary disease. The
atients were obese, with significantly higher resting heart
ate and blood pressure compared with control patients.
here were clear morphologic differences in the right and
eft ventricle between patients and control patients. The
ight ventricle was dilated and the interventricular septum
as thicker compared with control patients (p  0.001).
nly 2 of 43 patients had signs of left ventricular hypertro-
hy on the electrocardiogram. There was no further evi-
ence of ischemia or arrhythmia on the daytime electrocar-
iogram.
Functional data showed significantly lower left ventricular
jection fraction and stroke volume, as well as lower tissue
oppler-determined systolic and diastolic velocities for the
eft and right heart in patients compared with control
atients (Table 1). The right and left ventricular perfor-
ance was significantly reduced compared with control
atients, and the systolic pulmonary artery pressure was
orderline normal (32 10 mmHg). The arterial blood gas
nalysis showed normal daytime oxygen saturation (92 
%), with the minimal nighttime oxygen saturations (76 
%) being well below the accepted value of 88%.
We found higher AHI to be strongly associated with
ncreased right ventricular dimension (r  0.482, p 
.0009) and thicker interventricular septum (r  0.49, p 
.0009). Regarding functional parameters, a higher AHI
orrelated significantly with reduced tissue Doppler-derived
elocities measured at the mitral annulus, tricuspid annulus,
nd right ventricular free wall, as well as lower stroke
olume (Fig. 1). A weaker correlation was found with ESS,
hich reflects complaints of daytime sleepiness of the
atient (r  0.23, p  0.08). In the stepwise multiple
egression performed using AHI as the independent vari-
ble, interventricular septum thickness, right ventricular free
all, and mitral annulus tissue Doppler velocities were the
nly parameters retained, showing the most significant
ssociation with AHI (p  0.001).
Twenty-five of the original 43 patients were evaluated
fter 6 months of treatment with CPAP (administered
uring 6.8 h at night). The remaining patients did not
ollow the treatment plan for various reasons. At 6 months
fter treatment with CPAP, there was significant reduction
n the daytime sleepiness of the patients (ESS  5.3  4.0,
 0.0012) and improvements in hemodynamic, structural,
nd functional parameters measured (Table 2, Fig. 2). The
hanges in tissue Doppler-derived diastolic velocities and
he performance indices, however, did not reach signifi-
ance, because improvement was not invariably observed in
ll patients.
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bstructive sleep apnea is an underdiagnosed and undertreated
roblem with important cardiovascular consequences. A better
nderstanding and diagnosis of the cardiovascular conse-
uences and improved awareness of physicians is required, but
emains a challenge. The pathophysiological effects of ob-
tructive apnea on the cardiovascular system involve com-
lex mechanical, hemodynamic, neurohumoral, and inflam-
atory mechanisms (2).
We evaluated patients with severe OSA who were obese,
ad symptoms of daytime sleepiness, had no known cardiac
r obstructive pulmonary disease, had daytime hyperten-
ion, and had an increased resting heart rate. There is not
nly increased sympathetic activity during and in the im-
ediate post-apneic periods, but also the daytime sympa-
hetic nervous activity is increased two-fold (15). The
ssociation between OSA with occurrence of daytime hy-
ertension (22,23) and loss of nocturnal blood pressure dip
24) is known. Prospective confirmation of the association was
eported in the Wisconsin Sleep Cohort Study, in which AHI
as a significant independent predictor of daytime hyperten-
ion (25). The implications of this study are profound, indi-
igure 1. (A) Correlation between apnea-hypopnea index (AHI)
pnea-hypopnea index and left ventricle stroke volume (SV). (C) Corr
issue Doppler systolic velocities (RV Sm).
Table 2. Patient Data Before and Six Months A
Pressure (CPAP)
Heart rate (beats/min)
Stroke volume (ml)
Systolic/diastolic blood pressure (mm Hg) 1
Pulmonary artery pressure (mm Hg)
Interventricular septum thickness (cm) 1
Right ventricle dimension (cm)
Performance index (right ventricle) 0
Mitral annular Sm (cm/s)
Tricuspid annular Sm (cm/s) 1
Right ventricle free wall Sm (cm/s) 1
Epworth sleepiness score 1Sm  systolic tissue Doppler velocity.ating OSA as a new primary cause of hypertension and the
ecessity for increased physician awareness.
In our study we found structural and functional cardiac
lterations with right ventricular dilatation, left ventricular
ypertrophy, and reduced function of both. During apnea
he futile inspiratory efforts against the occluded pharynx
auses abrupt reductions in the intrathoracic pressure, with
nhancement of the venous return, distension of the right
entricle, and leftward shift of the interventricular septum
ausing a reduced filling of the left ventricle (26,27). There
s nocturnal pulmonary hypertension in virtually all patients
ith OSA (28). These are cyclic increases, associated with
pneic episodes and increased right ventricular dimensions.
he multiple mechanisms that mediate the nocturnal increase
n pulmonary artery pressure include alterations in blood gases,
ardiac output, lung volume, intrathoracic pressure, compliance
f the pulmonary circulation, and left ventricular diastolic
ysfunction (28). There are also early cineradiographic stud-
es in humans and dogs that showed increased right heart
ize during the apneic episodes (29). In awake patients, right
entricle dilatation, hypertrophy, and dysfunction was usu-
lly associated with concomitant lung disease and overt right
interventricular septum thickness (IVS). (B) Correlation between
n between apnea-hypopnea index and right ventricular (RV) free wall
reatment With Continuous Positive Airway
aseline After CPAP
11 67  10 (p  0.02)
10 71  11 (p  0.0037)
27/92  18 138  28/80  20 (p  0.03)
11 27  9 (p  0.009)
0.23 0.99  0.21 (p  0.001)
0.45 3.1  0.5 (p  0.0014)
0.1 0.28  0.15 (p  ns)
1.5 8.8  1.0 (p  0.0015)
1.9 13.9  2.1 (p  0.008)
2.1 12.2  1.8 (p  0.001)
4.8 5.3  4.0 (p  0.0001)andfter T
B
73 
64 
59 
32 
.32 
3.5 
.30 
7.9 
2.7 
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April 4, 2006:1433–9 Obstructive Sleep Apnea and Cardiac Alterationseart failure (30,31). However, in the absence of pulmonary
isease, radionuclide ventriculography studies of the right
entricle have shown association of reduced right ventricular
unction with hypercapnia while awake or AHI 40 (32),
r sympathetic hyperactivity that is typical of OSA (33). In
ur patients without evidence of clinically overt right heart
ailure, associated pulmonary disease, or awake hypercap-
ia, the right ventricle was dilated with reduced tissue
oppler-determined systolic and diastolic velocities, and
e found a significant association between these param-
ters and the AHI.
Systemic hypertension is the most common risk factor for
ardiac hypertrophy and failure in longitudinal studies, and
eft ventricular hypertrophy is more closely linked to hyper-
ension during sleep than during wakefulness (34). The
igher nocturnal blood pressure experienced in hypertensive
atients with OSA than in those without may place them at
greater risk for left ventricular hypertrophy (35). We found
highly significant correlation between the interventricular
eptum thickness and AHI (Fig. 1). The increase in
ransmural left ventricular pressure (difference between in-
racardiac and intrathoracic pressure), hence afterload, dur-
ng OSA episodes, in combination with the reduced filling
f the left ventricle, causes a reduction in the stroke volume
2). The stroke volume in our patients was reduced, and
nce again a significant association was found with the AHI
Fig. 1). The most direct mechanism by which OSA might
ompromise left ventricular systolic function is through its
ffect on blood pressure. All left ventricular functional
ndices (ejection fraction, tissue Doppler systolic velocities,
erformance index) measured in our patients were reduced.
he left and right ventricular diastolic function was invari-
bly altered in all patients.
Data on the coexistence of and association of pulmonary
ypertension in OSA are inconsistent (36,37), and little is
igure 2. (A) Changes in interventricular septum thickness (IVS) before
entricular stroke volume before and six months after continuous positive a
RV Sm) before and six months after continuous positive airway pressurenown of the prognostic implications of pulmonary hyper- mension in OSA. Alterations of humoral factors (natriuretic
eptides, nitric oxide, endothelin) (38–40) and individual
redisposition to different remodeling responses of the
ulmonary circulation to hypoxia have been implicated.
evere impairment of pulmonary hemodynamics occurs in
atients with concomitant lung disease and morbid obesity
31,36,41). Pulmonary hypertension at rest is present in
ewer than half of OSA patients, being mild in most cases
41), and right ventricular functional abnormalities are
hought to be partly independent of the coexistence of
iurnal pulmonary hypertension (33). The daytime oxygen
aturation was normal in our patients, and there was no
vidence for obstructive lung disease. The pulmonary pres-
ures were borderline normal and showed no significant
elationship with AHI. There was, however, consistent
ight ventricular dilatation and dysfunction in accordance
ith the severity of the apneas. There was significant
mprovement in these parameters after treatment with
PAP, providing support for the hypothesis that right
entricular dysfunction may be at least partly indepen-
ent of pulmonary hypertension and may be a conse-
uence of sympathetic hyperactivity and hemodynamic
erturbations related to OSA (33).
The structural and functional involvement of the left and
ight ventricle without the simultaneous occurrence of
ignificant pulmonary hypertension in patients with OSA
ould likely be a consequence of the state of hypoxia,
ncreased sympathetic drive, increased oxygen demand, and
he mechanical and hemodynamic perturbations. We found
clear relationship between severity of the apneic episodes
nd these changes. Six months after CPAP treatment, we
ound consistent improvement in structural and contractile
arameters (Table 2, Fig. 2) of both ventricles. The body
ass index (BMI) of the patients and the initial treatment
trategies remained unchanged. The observed improve-
six months after continuous positive airway pressure treatment. (B) Left
pressure treatment. (C) Right ventricular tissue Doppler systolic velocity
ent.andents are therefore most likely associated with treatment
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Obstructive Sleep Apnea and Cardiac Alterations April 4, 2006:1433–9ith CPAP, which abolishes the apneic episodes and
educes the sympathetic activity. Treatment with CPAP is
nalogous to the effects of chronic beta-blockade in heart
ailure. It is, however, achieved nonpharmacologically by
educing the oxygen demand, increasing the oxygen
upply, and altering the central sympathetic outflow (2).
he CPAP also improves the quality of sleep, decreases
aytime sleepiness, and augments neurocognitive func-
ion (2). The ESS was clearly improved in our patients.
t six months after treatment, changes in the diastolic
elocities were variable, with significant improvement in
ounger patients and variable improvement in older
atients. It is possible that improvement in diastolic
unction requires time (more than six months), or that
he presence of other confounding variables (older age,
ther comorbidity) remains problematic.
To conclude, we present a study showing structural and
unctional changes of the left and right ventricles that are
losely associated with the severity of obstructive apnea, and
how significant improvements at 6 months after treatment
ith CPAP. Cardiovascular physicians could easily use such
oninvasive, quantitative, and technically simple methodology
o assess cardiac alterations that may, without treatment, have
rofound cardiovascular consequences for their patients.
tudy limitations. We did not have BMI-matched control
atients. It is, however, difficult to find healthy, obese, middle-
ged patients without the presence of comorbidities (hyperten-
ion, metabolic syndrome, diabetes, and so on), which act as
onfounding factors and would potentially influence all mea-
urements performed in our study. The control patients were
ge-matched and overweight, with a mean BMI of 26.4
g/m2. Furthermore, after 6 months of treatment with CPAP,
e found significant improvements in a number of the mea-
ured parameters when the BMI and initial treatment strate-
ies remained unchanged. Therefore, to some degree the
hanges observed in the study seem to be independent of the
MI. Further, the study is small and nonrandomized. There
re, however, no large-scale studies involving long-term assess-
ent of cardiovascular alterations before and after various
reatment modalities. Also, randomized trials are a difficult
ssue because of the ethical considerations in withholding
PAP for prolonged periods from control groups.
eprint requests and correspondence: Dr. Bharati Shivalkar, De-
artment of Cardiology, University Hospital Antwerp, Wilrijkstraat
0, 2650 Edegem, Belgium. E-mail: bharati.shivalkar@skynet.be;
harati.shivalkar@uza.be.
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